Alimera Sciences RPE
Was ist das RPE von Alimera Sciences?
RPE von Alimera Sciences Inc. ist $204.684k
Was ist die Definition von RPE?
Umsatz pro Mitarbeiter (RPE) ist der Umsatz geteilt durch die Anzahl der Mitarbeiter einer Organisation.
RPE von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu Alimera Sciences
Was macht Alimera Sciences?
alimera, founded in june 2003, is a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. alimera is presently focused on diseases affecting the back of the eye, or retina, because these diseases are not well treated with current therapies and will affect millions of people in aging populations. alimera's commitment to retina specialists and their patients is manifest in its product and in its development portfolio designed to treat early- and late-stage diseases. for more information, please visit www.alimerasciences.com. alimera's european operations are conducted from london by its subsidiary, alimera sciences limited.
Unternehmen mit rpe ähnlich Alimera Sciences
- Coveo Solutions hat RPE von $204.448k
- Verint Systems hat RPE von $204.498k
- Nacon S.A hat RPE von €204.512k
- MJ Hudson plc hat RPE von £204.526k
- ConvaTec Plc hat RPE von $204.575k
- Shield Therapeutics Plc hat RPE von £204.600k
- Alimera Sciences hat RPE von $204.684k
- Société BIC SA hat RPE von €204.760k
- Metals Exploration plc hat RPE von $204.791k
- Edenred SA hat RPE von €204.929k
- Coherent Corp hat RPE von $204.958k
- Calibre Mining hat RPE von $205.044k
- Credit Corp hat RPE von AUD$205.326k